https://www.indianpharmapost.com/cadila-healthcare-signs-agreement-with-shilpa-medicare-for-production-of-zycov-d-103272021-09-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/us-fda-completes-inspection-of-biocon-biologics-malaysia-with-six-observations-103282021-09-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/sab-biotherapeutics-sab-185-moves-to-phase-3-trial-for-covid-19-treatment-103292021-09-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/medleymed-enters-the-us-market-with-a-suite-of-digital-health-solutions-103302021-09-26T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-pharma-india-receives-permission-for-paediatric-drug-103312021-09-26T00:00:00+05:30always0.9